These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18307235

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):22-4. PubMed ID: 19089931
    [No Abstract] [Full Text] [Related]

  • 3. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
    Wood FO, Saylors EK, Schneider JE, Jobe RL, Mann JT.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):533-8. PubMed ID: 18307224
    [Abstract] [Full Text] [Related]

  • 4. Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
    Hillegass WB.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):58-9. PubMed ID: 20578193
    [No Abstract] [Full Text] [Related]

  • 5. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
    Bailey SR.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):457-8. PubMed ID: 18819143
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of the First In Man experience with everolimus-eluting stents.
    Kimmelstiel C.
    Catheter Cardiovasc Interv; 2010 Jun 01; 75(7):1004-5. PubMed ID: 20517960
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. What kind of stent for you today and how would you like it prepared?
    Butman SM.
    Catheter Cardiovasc Interv; 2007 Aug 01; 70(2):173-4. PubMed ID: 17630654
    [No Abstract] [Full Text] [Related]

  • 11. The need for a dedicated bifurcation stenting system.
    Kornowski R.
    Catheter Cardiovasc Interv; 2009 Apr 01; 73(5):641-2. PubMed ID: 19309702
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Another small step for small vessels.
    Morrison DA.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):67-9. PubMed ID: 20578195
    [No Abstract] [Full Text] [Related]

  • 16. Drug-eluting stents or drug-eluting conduits for multivessel disease?
    Alfieri O, Maisano F, Benussi S, Toracca L, Castiglioni A.
    J Cardiovasc Med (Hagerstown); 2007 May 01; 8(5):359-61. PubMed ID: 17443103
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):448-56. PubMed ID: 18814218
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.